New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

VersiLac meets new gluten free rule

VersiLac meets new gluten free rule

Proliant Dairy Ingredients is pleased to announce that VersiLac®, its economical dairy solid, meets the final rule of the Food and Drug Administration’s definition for gluten free. The compliance date for this final rule is Aug. 5, 2014 and includes foods that inherently contain no gluten. Any unavoidable presence of gluten in the food must be below 20 parts per million (ppm).   

“According to the results of the ELISA R5- Mendez Method, VersiLac contains less than 5 ppm gluten, which is well below the required less than 20 ppm,” stated Mark Kuennen, Proliant’s director of quality assurance. 

The increasing number of people who experience gluten sensitivities or celiac disease is growing dramatically and the only recognized treatment remains a strict adherence to a gluten-free diet. Linda Myhr, Proliant Dairy’s director of sales, stated “Proliant Dairy is pleased to provide a gluten-free, economical, dairy ingredient that food manufacturers need in order to develop new and innovative gluten-free products.” 

VersiLac is a highly versatile and innovative dairy ingredient, and is the result of a unique combination of raw materials and a proprietary production process. Containing over 86 percent lactose, VersiLac provides food formulators a high-quality, low cost, dairy-based alternative to many higher priced dairy ingredients, including lactose, whey powder and nonfat dry milk/skim milk powder in a variety of food systems, all while maintaining a consistent dairy-based, gluten-free label. In addition to dairy ingredients, VersiLac has been proven to replace or reduce the amount of salt, sugar, chocolate and a variety of other nondairy ingredients.   

Study shows OmniActive's CurcuWIN more bioavailable

Study shows OmniActive's CurcuWIN more bioavailable

A well-controlled human clinical trial comparing standard curcumin and several commercial curcumin products with enhanced bioavailability showed CurcuWIN™ from OmniActive Health Technologies significantly increased serum curcuminoid levels 46 times over standard curcumin. CurcuWIN was also shown to be significantly more bioavailable than other enhanced curcumin ingredients.

The randomized, double-blind crossover study entitled "Comparative Absorption of Curcumin Formulations" was conducted by the University of Tampa in collaboration with Increnovo LLC, a leading contract research and consulting company supporting scientific, clinical research and product development in the dietary supplement and food and beverage categories.

The study showed an increase in serum levels of total curcuminoids (curcumin, demethoxycurcumin, bisdemethoxycurcumin) and the metabolite tetrahydrocurcumin after oral administration of three different curcumin formulations and an unformulated standard curcumin. Results were published by Nutrition Journal on Jan. 24. 

"Because this study was designed to have participants serve as their own control, a direct comparison could be made between the bioavailability of the curcumin ingredients tested," noted Jayant Deshpande, Ph.D., chief technical officer, OmniActive Health Technologies. "No other product has gone through this degree of testing in such a robust bioavailability model alongside multiple product forms. Now that we have established CurcuWIN's superior bioavailability and conducted preclinical studies, we plan additional clinicals to support its efficacy."

Twelve healthy individuals completed the study, testing each curcumin form under fasting conditions with a washout period between dosing. Standard FDA proposed bioavailability measures including AUC, Tmax, Cmax and relative absorption were conducted, and a more robust, conservative and rigorous statistical model was used to provide lower variability in the results. What made this particular study both unique and relevant is that it tested a bioavailable curcumin ingredient, in this case CurcuWIN, not only against standard curcumin but also against other enhanced curcumin products on the market.

OmniActive utilized its patented UltraSOL™ Dry Nutrient System Technology, a molecular dispersion process that enhances the solubility and bioavailability of lipophilic compounds and poorly absorbed nutrients, to develop CurcuWIN Turmeric Extract Powder. Patent-pending CurcuWIN provides 20 percent curcuminoids in the ratio in which they are naturally found in turmeric.


Cargill brings Filippo Berio Olive Oil to foodservice

Cargill brings Filippo Berio Olive Oil to foodservice

Cargill and Filippo Berio Olive Oil announced an agreement in which Cargill will be licensed to market a set of foodservice olive oil products under the Filippo Berio Culinary Selection brand. The agreement features five distinct olive oil products that meet the varying needs of foodservice operators, while maintaining the high-quality, delicious-tasting olive oil products that Filippo Berio is known for worldwide.

 “We are pleased to enter into this agreement with Cargill to further the distribution of Filippo Berio Olive Oil beyond the kitchens of home cooks, where our products have been a staple for 150 years, and into foodservice industry kitchens across the country,” said Massimo Saracchi, CEO of SALOV S.p.A., the owner of the Filippo Berio Olive Oil brand. “As olive oil consumption continues to grow rapidly in the United States, this partnership enables us to provide foodservice operators with products that meet the standard of quality set forth by our founder, Filippo Berio, himself.”

That long-standing commitment to quality attracted Cargill to the marketing agreement with Filippo Berio Olive Oil.

“Today’s foodservice operators need reputable sources of high-quality olive oil products,” said Gonzalo Petschen, president of Cargill Dressings, Sauces and Oils. “By partnering with Filippo Berio Olive Oil, we will provide our customers with products that consistently meet the varied application and sensory requirements of their foodservice operations, delivering the performance, flavor and versatility they demand.” 

The new line of Filippo Berio Culinary Selection olive oil products licensed to Cargill includes:

  • Filippo Berio Culinary Selection Extra Virgin Olive Oil, perfect for dressings and marinades, drizzling on top of foods, dipping and sautéing
  • Filippo Berio Culinary Selection Olive Oil, ideal for shallow pan frying, sautéing, grilling, baking and roasting
  • Filippo Berio Culinary Selection Sauté & Grill Oil, a blend of 80 percent high-oleic canola oil and 20 percent extra virgin olive oil for superior performance during high heat food preparations
  • Filippo Berio Culinary Selection All Purpose Oil, a blend of 75 percent conventional canola oil and 25 percent extra virgin oil for marinades, dressing and pizza dough
  • Filippo Berio Culinary Selection Every Day Oil, a blend of 85 percent conventional soybean oil and 15 percent olive oil, versatile for a variety of food preparations

Acids against Alzheimer's

A combo of omega-3 fatty acids and alpha lipoic acid may help put the brakes on Alzheimer's. A new study released in the Journal of Alzheimer's Disease and noted on noted the research.

The study, conducted at the Oregon Health & Science University in Portland, Oregon included 32 patients with Alzheimer's. Researchers studied the effects of supplementation with omega-3 fatty acid with and without lipoic acid over a year of treatment. Lipoic acid is an antioxidant found in certain foods including spinach, broccoli, red meat, potatoes, yams, carrots, beets and yeast. The human body also makes small amounts.

To measure the effects of the supplements, researchers analyzed oxidative stress biomarkers, including F2-isoprostane levels. They also measured the subjects' performance on "Mini-Mental State Examination (MMSE), Activities of Daily Living/Instrumental Activities of Daily Living (ADL/IADL), and Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog)."

They found that the two supplements did indeed help subjects. "The combination of omega-3 and lipoic acid slowed cognitive and functional decline in Alzheimer's disease over 12 months," the authors wrote.

Another study completed earlier this year in Italy suggested that lipoic acid may slow cognitive decline among Alzheimer's patients.

8 trend-setting natural and organic products from Fancy Foods 2014

The Winter Fancy Food Show, held each January in San Francisco, is attracting a growing number of natural and organic manufacturers and retailers. Among the booths of artisanal, handcrafted and gourmet products, I spotted many of the hot trends and ingredients that have recently emerged on the natural, organic and healthy market scene. Ancient grains, chia and coconut were all on massive display in San Francisco.

A growing number of specialty brands are also following the path pioneered by natural products companies, ditching GMO ingredients and artificial colors and flavors in favor of using real, whole food ingredients in their products. Many others are supporting strong social missions or philanthropic initiatives such as 1% for the Planet.

Here’s a roundup of eight natural and organic products that caught my attention at this year’s Winter Fancy Food Show. Pay attention because these products also provide a glimpse of what we’re sure to see at the upcoming 2014 Natural Products Expo West show, March 6-9 in Anaheim, Calif.

Pregnant ladies can go nuts!

Pregnant ladies can go nuts!

For ages, pregnant women were even more leery of eating nuts than they were of movie seats located far from the restroom. Recent research, however, suggests they can enjoy nuts without fearing that doing so will result in nut-allergic kids who can never know the joy of a PB&J.

The research was published online in JAMA Pediatrics and noted on the New York Times. Researchers studied data from 8,205 mothers who did not have nut allergies and their children born from 1990 to 1994. They found 140 cases of peanut or tree nut allergy among their offspring. After adjusting for age, race, season of birth, smoking, consumption of fruits and veggies and other factors, they found that mothers who consumed nuts at least five times a month were almost 70 percent less likely to have a baby with a nut allergy than those who ate nuts less than once a month.

"We showed an association between diet and allergy, but not cause and effect," the article's senior author, Dr. Michael C. Young, an allergist at Boston Chilren's Hospital, told the Times.

Still, Dr. Young said, “Previously, women were concerned that eating nuts during pregnancy probably would lead to an allergic baby, but our data dispels that. A woman who is pregnant can eat peanuts without fear that she will have a baby allergic to peanuts.”

Recently, researchers have been revealing more and more about how a mother's diet may affect their offspring's development. For example, if you're with child, and you fuel your pregnancy with the Dollar Menu at Micky D's, what to expect when you're expecting might be a child who grows up with a junk food habit.

Study shows curcumin micelle most bioavailable

Frutarom Switzerland Ltd., Health BU Switzerland, in conjunction with Aquanova AG, Darmstadt, Germany, is pleased to announce the results of a recently published human study examining the bioavailability of curcumin across three different oral delivery systems. 

Recognized as the most biologically active compound found in the turmeric rhizome (Curcuma longa), curcumin presents wide-ranging health benefits. Key to capitalizing on curcumin’s health benefits is improving its limited uptake into the body. The typically low systemic bioavailability of the lipophilic curcumin is attributed to its poor solubility in the aqueous phase of the digestive tract and its rapid metabolism and excretion from the body.

Over the past several years, new delivery systems have emerged and were touted for their potential to enhance uptake and retention. The study, “Oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sex, provides strong data demonstrating enhanced systemic uptake and sustained circulation of NovaSOL® curcumin micelles in comparison to both native curcumin and curcumin micronisate. 

“The numbers are exciting,” explains Jan Frank, PhD, professor at Hohenheim University’s Institute of Biological Chemistry and Nutrition, Stuttgart, Germany and the principal investigator on the recently-published human trial. “The AUC-[the area under the plasma concentration-time curve, which is the gold-standard measurement of the bioavailability of a compound] places the NovaSOL curcumin micelle head and shoulders above other delivery systems. This provides significant opportunities to truly utilize curcumin’s properties to maximum effect.”

Based on comparisons of plasma AUC, the study demonstrates significant differences between the three curcumin formulations with total AUC as follows: native curcumin 66 +/- 116 nmol/L×h, curcumin micronisate 583 +/- 289 nmol/L×h, and curcumin micelle 12148 +/- 4547 nmol/L×h. The numbers show a 185-fold higher AUC, demonstrating conclusively the superior bioavailability of the curcumin micelle compared to native curcumin.

Therefore, using a small single dose of NovaSOL curcumin is the bioavailable equivalent to high, multiple gram dosages of a standard extract.

Further studies, including an exploration of the differences in plasma concentration between men and women and the bioefficacy of micellar curcumin, are underway at Professor Frank’s laboratories.

Times reads the tea leaves wrong

The headline for the Sunday, Dec. 22 New York Times'  cover story could have been "Prescription Drugs Cause 80 Percent of Liver Disease Cases," rather than a headline that ties the increase in liver damage to supplements.  Natural Products Insider editor Sandy Almendarez points this out in a potent response to the Times' piece, "Spike In Harm to Liver Is Tied to Dietary Aids."

In her piece, Almendarez questions the accuracy of the Times' coverage of green tea extract and supplement in general. "This New York Times piece said, "the supplement business is largely unregulated," which isn't true. It also said, "Usually the agency must wait until consumers are harmed before officials can remove products from stores," which also is not true. Lastly, it said "the supplement industry operates on the honor system." Anyone testing and retesting to meet required GMPs (good manufacturing practices) knows this isn’t true."

The Times' story implies that drugs are safer because side effects are clearly stated and they have been vetted before coming to the market, writes Almendarez. "However, I fail to see how products that are linked to four times the amount of liver disease cases as supplements could be safer," she says.

Almendarez illuminates the potential for subjective reporting of data about the industry, as do Barry Ritz, the vice president of scientific and regulatory affairs at Atrium Innovations and Functional Ingredients editor Todd Runestad do on Newhope360 in their responses to the Times' editorial "Enough is Enough: Stop Wasting Money on Vitamin and Mineral Supplements."

Fenchem US reaches record sales in 2013

Fenchem US reaches record sales in 2013

Fenchem Inc. announces fiscal data for 2013, stating a significant sales jump of 60 percent compared with that of 2012. The sales volume reached a record of $25 million for Fenchem Inc. in the United States.

Focusing on specific products and always providing excellent and suitable products to meet customers’ needs gives Fenchem Inc. continuous power for business expansion. In 2013, our traditionally strong branded products, such as TOCOVET® Natural Vitamin E, HyaMax® Sodium Hyaluronate and In-fibre™ Organic Inulin, are still in a good position in food and nutriceutical markets. Moreover, breakthrough business in Fenchem Inc.’s Cosmetic and Personal Care sector, as well as its new Paint and Coatings sector, give Fenchem Inc. extra growth power in reaching the record sales. Business in these areas are projected to make up a larger portion of Fenchem Inc.’s 2014 sales, contributing to target sales of $40 million.

Fenchem Inc., located in Chino, Calif., is one of Fenchem’s five overseas offices. The other four branches are located in Czech Republic, Malaysia, South Africa and Germany. Fenchem Inc. is Fenchem’s first overseas office, aiming to better serve the U.S. and nearby customers in Canada and Mexico. With six years’ development, Fenchem Inc. is becoming more and more mature, supported by a stable sales and support team, doubling office and warehouse space, sufficient inventory and suitable product portfolio. Fenchem Inc. is now becoming one of the most important parts of Fenchem global business.

NutraClick named to Forbes' most promising companies list

NutraClick named to Forbes' most promising companies list

NutraClick, a technology-driven health and wellness products company, announced it has been named one of “America’s Most Promising Companies” by Forbes magazine. The third annual list scouts privately held, high-growth companies throughout the country, taking a comprehensive look at the competitive landscape, quality of management and investors, market size and potential and product strength.

Recognized for record growth, unique all-natural products and success without outside funding, NutraClick is the only health and wellness products company to make the list. The company’s mission is focused on producing cutting-edge natural products that help people lead better, healthier lives. This year, NutraClick will continue its accelerated path of innovation with the launch of new products that address a wider range of health and wellness needs, while expanding in key international markets including Brazil.

“We are thrilled to be recognized on such a prestigious ranking of high-growth companies,” said Daniel Wallace, CEO and cofounder of NutraClick. “It is a great testament to the work our team has done over the past five years, to build a truly unique company committed to innovation and product development that is revolutionizing the global health and wellness industry.”

Forbes’ list of America's Most Promising Companies features 100 privately held companies whose compelling business models, strong management teams, notable customers, strategic partners and precious investment capital have separated them as fast growing companies with impressive growth prospects. NutraClick is listed as #58 on Forbes’ third annual ranking of America’s Most Promising Companies.

NutraClick’s inclusion on Forbes’ list comes after a notable year for the company, which included unveiling a new 22,000 square-foot corporate headquarters, the addition of key executives to its leadership team, and the launch of two new brands, Femme Factor and ProbioSlim.